Stop the war!

Остановите войну!

for scientists:

default search action

combined dblp search
author search
venue search
publication search

ask others

Federico Marini 0002

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Harald Binder

> Home > Persons > Federico Marini 0002

Publications

2020
[j4]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/bmcbi/MariniLB20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/MariniLB20
Federico Marini, Jan Linke, Harald Binder:
ideal: an R/Bioconductor package for interactive differential expression analysis. BMC Bioinform. 21-S(1): 565 (2020)
2019
[j2]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/bmcbi/MariniB19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/MariniB19
Federico Marini, Harald Binder:
pcaExplorer: an R/Bioconductor package for interacting with RNA-seq principal components. BMC Bioinform. 20(1): 331:1-331:8 (2019)
2016
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/bib/PoplawskiMHZMB16
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bib/PoplawskiMHZMB16
Alicia Poplawski, Federico Marini, Moritz Hess, Tanja Zeller, Johanna Mazur, Harald Binder:
Systematically evaluating interfaces for RNA-seq analysis from a life scientist perspective. Briefings Bioinform. 17(2): 213-223 (2016)

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.